Wisconsin Collaborative for Quality Healthcare

View Our Reports

print this page

Ischemic Vascular Disease: Daily Aspirin or Other Antiplatelet Therapy Unless Contraindicated This is a measure developed by the Wisconsin Collaborative for Healthcare Quality (WCHQ).

Your Search Results: 57 Clinics in the Wheaton Franciscan Healthcare health system


The results below represent the care of 3,984 patients with coronary and other atherosclerotic vascular disease. Read More About This Measure

Reporting Period:

Sort By Rank | Sort By Name  
Btn Export
AS Gateway-Kenosha

The number of patients or providers is too small for
purposes of reliably reporting performance
SJ FL5 Women Outpatient Center

The number of patients or providers is too small for
purposes of reliably reporting performance
WFMG 1320 WI AVE FL 1 N
N=127
90.55 %
View Historical Data
WFMG 2500 LAYTON 220

The number of patients or providers is too small for
purposes of reliably reporting performance
WFMG AS 3807 FAM
N=292
96.23 %
View Historical Data
WFMG AS 3807 INT
N=536
95.71 %
View Historical Data
WFMG AS 3807 PED

The number of patients or providers is too small for
purposes of reliably reporting performance
WFMG AS CVI 410

The number of patients or providers is too small for
purposes of reliably reporting performance
WFMG AS ENDO

The number of patients or providers is too small for
purposes of reliably reporting performance
WFMG AS MT PLEASANT
N=147
91.84 %
View Historical Data
WFMG AS POB A 210

The number of patients or providers is too small for
purposes of reliably reporting performance
WFMG AS RACINE INSINKERATOR

The number of patients or providers is too small for
purposes of reliably reporting performance
WFMG AS SLHP FL1

The number of patients or providers is too small for
purposes of reliably reporting performance
WFMG AS Sturtevant
N=108
91.67 %
View Historical Data
WFMG BROOKFIELD CAPITOL
N=340
87.06 %
View Historical Data
WFMG BROOKFIELD CAPITOL WWOOD

The number of patients or providers is too small for
purposes of reliably reporting performance
WFMG BROWN DEER
N=128
85.16 %
View Historical Data
WFMG CUDAHY

The number of patients or providers is too small for
purposes of reliably reporting performance
WFMG EM MOB 400

The number of patients or providers is too small for
purposes of reliably reporting performance
WFMG EMAC 104W

The number of patients or providers is too small for
purposes of reliably reporting performance
WFMG EMAC 200E
N=245
92.65 %
View Historical Data
WFMG FOUR MILE
N=245
90.61 %
View Historical Data
WFMG FRK MOB FL 2
N=342
95.03 %
View Historical Data
WFMG FRK MOB FL 3

The number of patients or providers is too small for
purposes of reliably reporting performance
WFMG GLENDALE OBG

The number of patients or providers is too small for
purposes of reliably reporting performance
WFMG METRO MAP 114

The number of patients or providers is too small for
purposes of reliably reporting performance
WFMG MP 2500 LAYTON 10

The number of patients or providers is too small for
purposes of reliably reporting performance
WFMG MP 2745 LAYTON 201

The number of patients or providers is too small for
purposes of reliably reporting performance
WFMG MP 2745 LAYTON 206

The number of patients or providers is too small for
purposes of reliably reporting performance
WFMG MP 4600 LOOMIS 130
N=274
92.34 %
View Historical Data
WFMG MP CUDAHY

The number of patients or providers is too small for
purposes of reliably reporting performance
WFMG MP HALES CORNERS

The number of patients or providers is too small for
purposes of reliably reporting performance
WFMG MP NEW BERLIN 210

The number of patients or providers is too small for
purposes of reliably reporting performance
WFMG MP RAWSON G30

The number of patients or providers is too small for
purposes of reliably reporting performance
WFMG MP S 16TH

The number of patients or providers is too small for
purposes of reliably reporting performance
WFMG MP SF MAP 100
N=118
95.76 %
View Historical Data
WFMG MP SF MAP 122

The number of patients or providers is too small for
purposes of reliably reporting performance
WFMG MP SF MAP 124

The number of patients or providers is too small for
purposes of reliably reporting performance
WFMG MP SF OHIO 103

The number of patients or providers is too small for
purposes of reliably reporting performance
WFMG NEW BERLIN

The number of patients or providers is too small for
purposes of reliably reporting performance
WFMG ONE MAIN
N=211
96.21 %
View Historical Data
WFMG ORCHARD ST

The number of patients or providers is too small for
purposes of reliably reporting performance
WFMG PEWAUKEE

The number of patients or providers is too small for
purposes of reliably reporting performance
WFMG RAWSON 143

The number of patients or providers is too small for
purposes of reliably reporting performance
WFMG RAWSON G30
N=103
94.17 %
View Historical Data
WFMG SF EUCLID 1000
N=115
93.91 %
View Historical Data
WFMG SF MAP 102 CRDEP

The number of patients or providers is too small for
purposes of reliably reporting performance
WFMG SF MAP 105 CRD

The number of patients or providers is too small for
purposes of reliably reporting performance
WFMG SJ FL 7W

The number of patients or providers is too small for
purposes of reliably reporting performance
WFMG SJ POB 106

The number of patients or providers is too small for
purposes of reliably reporting performance
WFMG SJ POB FL 6
N=106
99.06 %
View Historical Data
WFMG SUSSEX
N=134
90.30 %
View Historical Data
WFMG TOSA FL 2
N=312
91.99 %
View Historical Data
WFMG TOSA FL 2 CRD

The number of patients or providers is too small for
purposes of reliably reporting performance
WFMG TOSA FL 3 OBG

The number of patients or providers is too small for
purposes of reliably reporting performance
WFMG TOSA N 117TH 200

The number of patients or providers is too small for
purposes of reliably reporting performance
WFMG UNION GROVE
N=101
96.04 %
View Historical Data

There has been important evidence from clinical trials that further supports and broadens the merits of risk-reduction therapies for patients with established coronary and other atherosclerotic vascular disease, including peripheral arterial disease, atherosclerotic aortic disease, and carotid artery disease.

Based on trials involving other secondary prevention therapies, the ACC and AHA recommends aspirin in all patients, unless contraindicated, with established coronary and other atherosclerotic vascular disease, including peripheral arterial disease, atherosclerotic aortic disease, and carotid artery disease. The ACC and AHA also recommend the use of other antiplatelet agents based on disease type and clinical conditions.

This measure shows the percentage of people 18 to 75 years of age with a diagnosis coronary or other atherosclerotic vascular disease who were prescribed oral antiplatelet therapy, unless contraindicated, in the measurement year.


Disclaimer: Measures reported by WCHQ healthcare organizations represent a specific aspect of care in relation to an evidence-based standard, but are not clinical guidelines and do not establish standards of care.